ICU Medical Inc: Form 10-K for the period ended Dec 31, 2013
Filed with the SEC on Feb 21, 2014 and accepted by EDGAR at Feb 21, 2014, 15:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-10-01 to 2013-12-31 | $77.9m | us-gaap:Revenues |
| Revenue | 12 months2013-01-01 to 2013-12-31 | $313.7m | us-gaap:Revenues |
| Cost of revenue | 12 months2013-01-01 to 2013-12-31 | $159.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2013-10-01 to 2013-12-31 | $38.9m | us-gaap:GrossProfit |
| Gross profit | 12 months2013-01-01 to 2013-12-31 | $154.7m | us-gaap:GrossProfit |
| Research and development | 12 months2013-01-01 to 2013-12-31 | $12.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2013-01-01 to 2013-12-31 | $90.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2013-01-01 to 2013-12-31 | $51.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2013-01-01 to 2013-12-31 | $12.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-10-01 to 2013-12-31 | $13.3m | us-gaap:NetIncomeLoss |
| Net income | 12 months2013-01-01 to 2013-12-31 | $40.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-10-01 to 2013-12-31 | $0.86 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2013-01-01 to 2013-12-31 | $2.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-10-01 to 2013-12-31 | $0.89 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2013-01-01 to 2013-12-31 | $2.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2013-01-01 to 2013-12-31 | 15,274,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2013-01-01 to 2013-12-31 | $65.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2013-01-01 to 2013-12-31 | $18.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2013-01-01 to 2013-12-31 | $3.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2013-12-31 | $226.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-12-31 | $394.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-12-31 | $499.6m | us-gaap:Assets |
| Current liabilities | At period end2013-12-31 | $26.9m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2013-12-31 | $464.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000883984-14-000012. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.